Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA

Journal of Steroid Biochemistry and Molecular Biology

Volumn 57, Issue 1-2, 1996, Pages 51-66

  Klinge, Carolyn M ^a   Traish, Abdulmaged M ^b   Bambara, Robert A ^a   Hilf, Russell ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ESTRADIOL; ESTROGEN RECEPTOR; TAMOXIFEN AZIRIDINE;

ARTICLE; BINDING AFFINITY; DNA BINDING; DRUG RECEPTOR BINDING; HUMAN; PROTEIN MODIFICATION;

EID: 0029873531     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00246-4     Document Type: Article

References (82)

1. Green S. and Chambon P.: The oestrogen receptor: from perception to mechanism. In Nuclear Hormone Receptors (Edited by M. G. Parker). Academic Press, New York (1991) pp. 15-38.
2. O'Malley B. W.: Steroid hormone receptors as transactivators of gene expression. Breast Cancer Res. Treat. 18 (1991) 67-71.
3. Wahli W. and Martinez E.: Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression. FASEB J. 5 (1991) 2243-2249.
4. Orti E., Bodwell J. E. and Munck A.: Phosphorylation of steroid hormone receptors. Endocrine Rev. 13 (1992) 105-128.
5. Ali S., Metzger D., Bornert J. M. and Chambon P.: Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J. 12 (1993) 1153-1160.
6. Arnold S. F., Obourn J. D., Jaffee H. and Notides A. C.: Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by Src family tyrosine kinases in vitro. Molec. Endocr. 9 (1995) 24-33.
7. Denton R. R., Koszewski N. J. and Notides A. C.: Estrogen receptor phosphorylation. J. Biol. Chem. 267 (1992) 7263-7268.
8. LeGoff P., Montano M. M., Schodin D. J. and Katzenellenbogen B. S.: Phosphorylation of the human estrogen receptor. J. Biol. Chem. 269 (1994) 4458-4466.
9. Fritsch M., Welch R. D., Murdoch F. E., Anderson I. and Gorski J.: DNA allosterically modulates the steroid binding domain of the estrogen receptor. J. Biol. Chem. 267 (1992) 1823-1828.
10. Gronemeyer H.: Transcription activation by estrogen and progesterone receptors. An. Rev. Genet. 25 (1991) 89-123.
11. Bohen S. P. and Yamamoto K. R.: Isolation of hsp90 mutants by screening for decreased steroid receptor function. Proc. Natn. Acad. Sci. U.S.A. 90 (1993) 11,424-11,428.
12. Landel C. C., Kushner P. J. and Greene G. L.: The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Molec. Endocr. 8 (1994) 1407-1419.
13. Pratt W. B., Scherrer L. C., Hutchison K. A. and Dalman F. C.: A model of glucocorticoid receptor unfolding and stabilization by a heat shock protein complex. J. Steroid Biochem. Molec. Biol. 41 (1992) 223-229.
14. Smith D. F. and Toft D. O.: Steroid receptors and their associated proteins. Molec. Endocr. 7 (1993) 4-11.
15. Srinivasan G., Patel N. T. and Thompson E. B.: Heat shock protein is tightly associated with the recombinant human glucocorticoid receptor: glucocorticoid response element complex. Molec. Endocr. 8 (1994) 189-196.
16. Tai P. K. K., Albers M., Chang H., Faber L. E. and Schreiber S. L.: Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex. Science 256 (1992) 1315-1318.
17. Tai P. K. K., Chang H., Albers M., Schreiber S. L., Toft D. O. and Faber L. E.: P59 (FK506 Binding Protein 59) interaction with heat shock proteins is highly conserved and may involve proteins other than steroid receptors. Biochemistry 32 (1993) 8842-8847.
18. Peirrat B., Heery D. M., Chambon P. and Losson R.: A highly conserved region in the hormone-binding domain of the human estrogen receptor functions as an efficient transactivation domain in yeast. Gene 143 (1994) 193-200.
19. Jordan V. C.: The strategic use of antiestrogens to control the development and growth of breast cancer. Cancer 70 (1992) 977-982.
20. Lerner L. J. and Jordan V. C.: Development of antiestrogens and their use in breast cancer Cancer Res. 50 (1990) 4177-4189.
21. Katzenellenbogen B. S., Norman M. J., Eckert R. L., Peltz S. W. and Mange W. F.: Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxytamoxifen isomers in MCF-7 human breast cancer cells. Cancer Res. 44 (1984) 112-119.
22. Robertson D. W., Wei L. L., Hayes J. R., Carlson K. E., Katzenellenbogen J. A. and Katzenellenbogen B. S.: Tamoxifen aziridines: effective inactivators of the estrogen receptors. Endocrinology 109 (1981) 1298-1300.
23. 3H]tamoxifen aziridine. J. Biol. Chem. 258 (1983) 3487-3495.
24. Berry M., Metzger D. and Chambon P.: Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9 (1990) 2811-2818.
25. Klein-Hitpass L., Cato A. C. B., Henderson D. and Ryffel, G. U.: Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells. Nucl. Acids Res. 19 (1991) 1227-1234.
26. Wei L. L., Mangel W. F. and Katzenellenbogen B. S.: Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor in vivo and in vitro. J. Steroid Biochem. 23 (1985) 875-881.
27. Klinge C. M., Bambara R. A. and Hilf R.: What differentiates antiestrogen-liganded versus estradiol-liganded estrogen receptor action? Oncol. Res. 4 (1992) 137-144.
28. Cushing C. L., Bambara R. A. and Hilf R.: Interactions of estrogen-receptor and antiestrogen receptor complexes with nuclei in vitro. Endocrinology 116 (1985) 2419-2429.
29. Klinge C. M., Bambara R. A., Zain S. and Hilf R.: Estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues in vitro. Cancer Res. 47 (1987) 2852-2859.
30. Klinge C. M., Knox D. T., Bambara R. A., Zain S. and Hilf R.: Antiestrogen (4-hydroxytamoxifen)-charged estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues is not affected by host hormonal status. J. Steroid Biochem. 33 (1989) 335-340.
31. Ludwig L. B., Klinge C. M., Peale F. V. Jr., Bambara R. A., Zain S. and Hilf R.: A microtiter well assay for quantitative measurement of estrogen receptor binding to estrogen-responsive elements. Molec. Endocr. 4 (1990) 1027-1033.
32. Klinge C. M., Peale F. V. Jr., Hilf R., Bambara R. A. and Zain S.: Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro. Cancer Res. 52 (1992) 1073-1081.
33. Anolik J. H., Klinge C. M., Bambara R. A. and Hilf R.: Differential impact of flanking sequences on estradiol-versus 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA. J. Steroid Biochem. Molec. Biol. 46 (1993) 713-730.
34. Anolik J. H., Klinge C. M., Hilf R. and Bambara R. A.: Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand. Biochemistry 34 (1995) 2511-2520.
35. Klinge C. M., Bambara R. A. and Hilf R.: Antiestrogen-liganded estrogen receptor interaction with estrogen responsive elements DNA in vitro. J. Steroid Biochem. Molec. Biol. 43 (1992) 249-262.
36. Wakeling A. E. and Bowler J. J.: Steroidal pure antioestrogens. J. Endocr. 112 (1987) R7-R10.
37. Wakeling A. E. and Bowler J. J.: Biology and mode of action of pure antioestrogens. J. Steroid Biochem. 30 (1988) 141-147.
38. Peale F. V., Ludwig L. B., Zain S., Hilf R. and Bambara R. A.: Properties of a high-affinity DNA binding site for estrogen receptor. Proc. Natn. Acad. Sci. U.S.A. 85 (1988) 1038-1042.
39. Pavlik E. J. and Coulson P. B.: Hydroxylapatite "batch" assay for estrogen receptor: increased sensitivity over present receptor assays. J. Steroid. Biochem. 7 (1976) 357-368.
40. Hoopes B. C., LeBlanc J. F. and Hawley D. K.: Kinetic analysis of yeast TFIID-TATA box complex formation suggests a multi-step pathway. J. Biol. Chem. 267 (1992) 11,539-11,547.
41. Traish A. M., Al-Fadhili S., Klinge C., Kounine M. and Quick T. C.: Identification of structurally altered estrogen receptors in human breast cancer by site-directed monoclonal antibodies. Steroids 60 (1995) 467-474.
42. Murdoch F. E., Meier D. A., Furlow J. D., Grunwald K. A. A. and Gorski J.: Estrogen receptor binding to a DNA response element in vitro is not dependent upon estradiol. Biochemistry 29 (1990) 8377-8385.
43. Notides A. C. and Nielsen S.: The molecular mechanism of the in vitro 4 S to 5 S transformation of the uterine estrogen receptor. J. Biol. Chem. 249 (1974) 1866-1873.
44. Salomonsson M., Carlsson B. and Haggblad J.: Equilibrium hormone binding to human estrogen receptors in highly diluted cell extracts is non-cooperative and has a Kd of approximately 10 pM. J. Steroid Biochem. Molec. Biol. 50 (1994) 313-318.
45. Thole H. H.: The side chains responsible for the dimerization of the estradiol receptor by ionic bonds are lost in a 17 kDa fragment extending downstream from aa 303. J. Steroid Biochem. Molec. Biol. 50 (1994) 463-366.
46. Curtis S. W. and Korach K. S.: Uterine estrogen receptor interaction with estrogen-responsive DNA sequences in vitro: effects of ligand binding on receptor-DNA complexes. Molec. Endocr. 4 (1990) 276-286.
47. Curtis S. W. and Korach K. S.: Uterine estrogen receptor-DNA complexes: effects of different ERE sequences, ligands, and receptor forms. Molec. Endcrinol. 5 (1991) 959-966.
48. Kraus W. L., Montano M. M. and Katzenellenbogen B. S.: Identification of multiple, widely spaces estrogen-responsive regions in the rat progesterone receptor gene. Molec. Endocr. 8 (1994) 952-969.
49. Reese J. C. and Katzenellenbogen B. S.: Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells. Nucl. Acids Res. 19 (1991) 6595-6602.
50. Metzger D., Berry M., Ali S. and Chambon P.: Effect of antagonists of DNA binding properties of the human estrogen receptor in vitro and in vivo. Molec. Endocr. 9 (1995) 579-591.
51. Ojasoo T., Raynaud J. P. and Dore J. C.: Affiniation among steroid receptors as revealed by multivariate analysis of steroid binding data. J. Steroid Biochem. Molec. Biol. 48 (1994) 34-46.
52. Rossini G. P. and Camellinie L.: Oligomeric structures of cytosoluble estrogen-receptor complexes as studied by anti-estrogen receptor antibodies and chemical crosslinking of intact cells. J. Steroid Biochem. Molec. Biol. 50 (1994) 241-252.
53. Peale F. V. Jr., Ishibe Y., Klinge C. M., Zain S., Hilf R. and Bambara R. A.: Rapid purification of the estrogen receptor by sequence-specific DNA affinity chromatography. Biochemistry 28 (1989) 8671-8675.
54. Kumar V. and Chambon P.: The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55 (1988) 145-146.
55. Webster N. J. G., Green S., Jin J. R. and Chambon P.: The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54 (1988) 199-207.
56. Beekman J. M., Allan G. F., Tsai S. Y., Tsai M. J. and O'Malley B. W.: Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Molec. Endocr. 7 (1993) 1266-1274.
57. Fawell S. E., Lees J. A., White R. and Parker M. G.: Characterization and co-localization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60 (1990) 953-962.
58. Fawell S. E., White R., Hoare S., Syndenham M., Page M. and Parker M. G.: Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc. Natn. Acad. Sci. U.S.A. 87 (1990) 6883-6887.
59. Klein-Hitpass L., Tsai S. Y., Green G. L., Clark J. H., Tsai M. J. and O'Malley B.: Specific binding of estrogen receptor to the estrogen response element. Molec. Cell Biol. 9 (1989) 43-49.
60. Medici N., Nigro V., Abbondanzi C., Moncharmont B., Molinari A. M. and Puca G. A.: In vitro binding of the purified hormone-binding subunit of the estrogen receptor to oligonucleotides containing natural or modified sequences of an estrogen-responsive element. Molec. Endocr. 5 (1991) 555-563.
61. Murdoch F. E. and Gorski J.: The role of ligand in estrogen receptor regulation of gene expression. Molec. Cell Endocr. 78 (1991) C103-C108.
62. Zhuang Y., Katzenellenbogen B. S. and Shapiro D. J.: Estrogen receptor mutants which do not bind 17β-estradiol dimerize and bind to the estrogen response element in vivo. Molec. Endocr. 9 (1995) 457-466.
63. Furlow J. D., Murdoch F. E. and Gorski J.: High affinity binding of the estrogen receptor to a DNA response element does not require homodimer formation or estrogen. J. Biol. Chem. 268 (1993) 12,519-12,525.
64. Nardulli A. M., Greene G. L. and Shapiro D. J.: Purified estrogen receptor DNA binding domain expressed in Escherichia coli activates transcription of an estrogen-responsive promoter in cultured cells. Molec. Endocr. 7 (1993) 331-340.
65. Halachmi S., Marden E., Martin G., MacKay H., Abbondanza C. and Brown M.: Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264 (1994) 1455-1458.
66. Ing, N. H., Beekman J. M., Tsai S. Y., Tsai M. J. and O'Malley B. W.: Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J. Biol. Chem. 267 (1992) 17,617-17,623.
67. Corthesy B., Hipskind R., Theulaz I. and Wahli W.: Estrogen-dependent in vitro transcription from the vitellogenin promoter in liver nuclear extracts. Science 239 (1988) 1137-1139.
68. McDonnel D. P., Nawaz Z. and O'Malley B. W.: In situ distinction between steroid receptor binding and transactivation at a target gene. Molec. Cell. Biol. 11 (1991) 4350-4355.
69. Reese J. C. and Katzenellenbogen B. S.: Examination of the DNA-binding ability of estrogen receptor in whole cells: implications for hormone-independent transactivation and actions of antiestrogens. Molec. Cell Biol. 12 (1992) 4531-4538.
70. Harlow K. W., Smith D. N., Katzenellenbogen J. A., Greene G. A. and Katzenellenbogen B. S.: Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor. J. Biol. Chem. 264 (1989) 17,476-17,485.
71. Schwabe J. W. R., Neuhaus D. and Rhodes D.: Solution structure of the DNA-binding domain of the oestrogen receptor. Nature 348 (1990) 458-461.
72. Schwabe J. W. R., Chapman L., Finch J. R. and Rhodes D.: The crystal structure of the oestrogen receptor DNA-binding domain to DNA: how receptors discriminate between their response elements. Cell 75 (1993) 567-578.
73. Miller M. A., Mullick A., Greene G. L. and Katzenellenbogen B. S.: Characterization of the subunit nature of nuclear estrogen receptors by chemical cross-linking and dense amino acid labeling. Endocrinology 117 (1985) 515-522.
74. Ylikomi T., Bocquel M. T., Berry M., Gronemeyer H. and Chambon P.: Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors. EMBO J. 11 (1992) 3681-3694.
75. Mader S., Kumar V., de Verneuil H. and Chambon P.: Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid responsive element. Nature 338 (1989) 271-274.
76. Chang T. C., Nardulli A. M., Lew D. and Shapiro D. J.: The role of estrogen response elements in the expression of the Xenopus laevis vitellogenin B1 gene. Molec. Endocr. 6 (1992) 346-354.
77. Xing H., Haase S. and Shapiro D. J.: Antiestrogens activate an estrogen receptor mutant exhibiting enhanced binding to the estrogen response element. Biochem. Biophys. Res. Commun. 202 (1994) 888-895.
78. Neff S., Sadowski C. and Kiksicek R. J.: Mutational analysis of cysteine residues within the hormone-binding domain of the human estrogen receptor identifies mutants that are defective in both DNA-binding and subcellular distribution. Molec. Endocr. 8 (1994) 1215-1223.
79. Kato S., Tora L., Yamauchi J., Masushige S., Bellard M. and Chambon P.: A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5′-TGACC-3′ motifs acting synergistically. Cell 68 (1992) 731-742.
80. Webster N. J. G., Green S., Jin J. R. and Chambon P.: The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54 (1988) 199-207.
81. Driscoll M. D., Klinge C. M., Hilf R. and Bambara R. A.: Estrogen receptor affinity for consensus estrogen response elements is independent of ligand and adjacent estrogen response elements. J. Steroid Biochem. molec. Biol. (1996) in press.
82. Dove S. and Schonenberger H.: Computer modeling of estrogenic transcriptional activation can account for different types of dose-response curves of estrogens. J. Steroid Biochem. Molec. Biol. 46 (1993) 163-176.